Two Sigma Securities’s Cadrenal Therapeutics CVKD Stock Holding History

Two Sigma Securities’s Portfolio CVKD Stock Details CVKD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,057	Closed	-$7.45K	–	3009
2024 Q2	$7.45K	Buy	+1,057	New	+$7.31K	﹤0.01%	2839
2023 Q4	–	Sell	-722	Closed	-$7.37K	–	3119
2023 Q3	$7.37K	Buy	+722	New	+$10.3K	﹤0.01%	2746

Other funds holding CVKD

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Two Sigma Securities's CVKD Position: Q3 2024 in Review

Two Sigma Securities sold out of Cadrenal Therapeutics (CVKD) in Q3 2024, closing a stake of 1,057 shares — an estimated $7.45K sold.

Two Sigma Securities first reported a position in CVKD in Q3 2023 and held it in 2 quarters. The position peaked at $7.45K in Q2 2024. 2 funds tracked by Wall St. Rank hold CVKD as of Q3 2024.

Two Sigma Securities reported no remaining Cadrenal Therapeutics position as of Q3 2024 after selling out during the quarter.
Two Sigma Securities sold 1,057 Cadrenal Therapeutics shares in Q3 2024, an estimated $7.45K.
Two Sigma Securities first reported a position in Cadrenal Therapeutics in Q3 2023 and held it in 2 quarters.
Two Sigma Securities's Cadrenal Therapeutics position peaked at $7.45K in Q2 2024.
2 funds tracked by Wall St. Rank held Cadrenal Therapeutics as of Q3 2024.

Based on Two Sigma Securities's 13F filing for Q3 2024, filed 14 Nov 2024.